Detalles de la búsqueda
1.
A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
Am J Gastroenterol
; 118(8): 1373-1380, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36728217
2.
BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosis.
Mod Pathol
; 35(4): 480-488, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34764434
3.
A prognostic index for extranodal marginal-zone lymphoma based on the mucosa-associated lymphoid tissue International Prognostic Index and serum ß2-microglobulin levels.
Br J Haematol
; 193(2): 307-315, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33216979
4.
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.
Ann Hematol
; 100(10): 2529-2539, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34304287
5.
Diagnostic utility of STAT6YE361 expression in classical Hodgkin lymphoma and related entities.
Mod Pathol
; 33(5): 834-845, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31822802
6.
Long-term follow-up of abbreviated R-CHOP chemoimmunotherapy for completely resected limited-stage diffuse large B cell lymphoma (CISL 12-09).
Ann Hematol
; 99(12): 2831-2836, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32989495
7.
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis.
Ann Hematol
; 99(6): 1283-1291, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32333154
8.
Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report.
Ann Hematol
; 99(2): 223-228, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31853704
9.
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma.
Ann Hematol
; 99(2): 255-264, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31897676
10.
Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study).
Am J Hematol
; 95(4): 413-421, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31919872
11.
Treatment with intravenous busulfan, melphalan, and etoposide followed by autologous stem cell transplantation in patients with non-Hodgkin's lymphoma: a multicenter study from the consortium for improving survival of lymphoma.
Transpl Int
; 33(10): 1211-1219, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32479690
12.
Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma.
BMC Cancer
; 19(1): 1080, 2019 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31707975
13.
Pharmacokinetic and pharmacodynamic study of lenograstim for hematopoietic stem cell mobilization: a prospective randomized study for optimal apheresis.
Transfusion
; 59(5): 1781-1788, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30924165
14.
Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma.
Ann Hematol
; 98(7): 1657-1664, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30989325
15.
Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma.
Ann Hematol
; 98(11): 2541-2550, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31493002
16.
Brief report: Clinical experiences after emergency use of daratumumab monotherapy for relapsed or refractory multiple myeloma in real practice.
Jpn J Clin Oncol
; 49(1): 92-95, 2019 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30476124
17.
Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy.
Invest New Drugs
; 36(5): 877-885, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29520651
18.
Epstein-Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin's lymphoma.
Hematol Oncol
; 36(1): 182-188, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28744882
19.
Complete metabolic response (CMR) in positron emission tomography-computed tomography (PET-CT) scans may have prognostic significance in patients with marginal zone lymphomas (MZL).
Hematol Oncol
; 36(1): 56-61, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28401574
20.
The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms.
Ann Hematol
; 97(12): 2363-2372, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30069703